证券代码：002783 证券简称：凯龙股份 公告编号：2024－034 湖北凯龙化工集团股份有限公司 关于增设募集资金专户并签订募集资金监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 湖北凯龙化工集团股份有限公司（以下简称"公司"）根据向特定对象发行股 票募集资金投资项目的需要，于近日新增设立募集资金专项账户，并联同保荐机 构、存放募集资金的商业银行签署了《募集资金三方监管协议》，现将相关情况 公告如下： 一、募集资金基本情况 2024 年 2 月 6 日，公司收到中国证券监督管理委员会"证监许可[2024]221 号"文《关于同意湖北凯龙化工集团股份有限公司向特定对象发行股票注册的批 复》，同意公司向特定对象发行不超过 117,371,650 股的普通股（A 股）股票。公 司于 2024 年 3 月 29 日启动向特定对象发行股票工作，募集资金总额为人民币 849,999,994.56 元，扣除各项发行费用人民币 11,976,981.13 元（不含税）后，实 际募集资金净额为人民币 838,023,013.43 元。上述资金已于 2024 ...

Financial Performance - The company's operating revenue for Q1 2024 was ¥675,101,157.66, a decrease of 13.92% compared to ¥784,306,846.55 in the same period last year[5] - Net profit attributable to shareholders was ¥26,783,703.63, down 8.75% from ¥29,351,047.03 year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥16,717,525.98, reflecting a decline of 26.75% compared to ¥22,823,509.74 in the previous year[5] - Net profit for Q1 2024 was CNY 36,896,138.70, a slight decrease of 3.4% compared to CNY 38,180,137.66 in Q1 2023[22] - The company reported a profit margin of approximately 5.5% for Q1 2024, compared to 4.9% in the previous year[22] - Basic earnings per share for Q1 2024 were CNY 0.07, down from CNY 0.08 in Q1 2023[23] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 150.24%, reaching ¥104,404,606.40, compared to ¥41,722,271.70 in the same period last year[5] - The company reported a significant increase in cash flow from operations, indicating improved liquidity and operational efficiency[5] - Total cash inflow from operating activities was CNY 770,463,636.65, a decrease of 19.2% from CNY 954,527,865.70 in the same period last year[24] - Net cash flow from financing activities was CNY 53,895,772.21, a decrease of 53.0% compared to CNY 114,802,899.72 in the previous year[24] - The ending balance of cash and cash equivalents was CNY 494,055,238.38, down from CNY 644,978,051.19 at the end of Q1 2023[24] - Cash inflow from financing activities was CNY 463,002,680.43, a decrease of 27.5% from CNY 638,677,000.96 in the previous year[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥7,437,447,556.00, a slight decrease of 0.34% from ¥7,463,096,757.89 at the end of the previous year[5] - Total liabilities decreased to CNY 4,895,872,819.52 from CNY 4,960,111,240.42 in the previous quarter[19] - The company's goodwill remained stable at CNY 40,782,404.92, unchanged from the previous quarter[19] - The total equity attributable to shareholders of the parent company increased to CNY 1,597,445,630.81 from CNY 1,571,387,453.53 in the previous quarter[19] Investments and Income - Other income increased by 163.22% to ¥8,166,000.00 due to an increase in government subsidies related to revenue[10] - Investment income surged by 3,139.19% to ¥5,111,490.00, primarily from dividends received from Jiangsu Hongguang Chemical Co., Ltd.[10] - The company reported an investment income of CNY 52,743,225.67 for Q1 2024, significantly up from CNY 1,628,286.57 in the same period last year[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 27,914, with the largest shareholder holding 15.28% of the shares[12] - Shareholders' equity attributable to the parent company increased by 1.66% to ¥1,597,445,630.81 from ¥1,571,387,453.53 at the end of the previous year[5] Future Plans and Strategic Moves - The company plans to issue shares to no more than 35 specific investors, including its controlling shareholder, to raise funds not exceeding RMB 85,000,000[14] - The company has signed an agreement to issue shares, which has been approved by the relevant regulatory authorities, indicating a strategic move for capital raising[14] Operational Efficiency - Total operating costs for Q1 2024 were CNY 650,281,740.07, down 13.1% from CNY 748,061,715.04 year-over-year[20] - Research and development expenses for Q1 2024 were CNY 12,903,572.77, a decrease of 26.5% from CNY 17,581,673.72 in Q1 2023[20] Inventory and Receivables - Accounts receivable decreased to RMB 700,748,990.25 from RMB 650,351,469.12, indicating a reduction of about 7.7%[17] - Inventory increased to RMB 429,932,580.57 from RMB 405,946,344.07, reflecting an increase of approximately 5.9%[17] Asset Changes - The company’s fixed assets decreased to RMB 3,166,511,407.81 from RMB 3,234,728,982.30, a decline of about 2.1%[17] - The company’s intangible assets slightly decreased to RMB 1,025,028,294.19 from RMB 1,027,044,578.81, a reduction of approximately 0.2%[17] - Long-term equity investments rose slightly to RMB 227,329,634.13 from RMB 224,371,458.47, showing an increase of approximately 1.3%[17] Audit and Reporting - The first quarter report was not audited[25]

Financial Performance - The company's Q1 2024 revenue was CNY 675.10 million, a decrease of 13.92% compared to the same period last year[2] - Net profit attributable to shareholders for Q1 2024 was CNY 26.78 million, down 8.75% year-over-year[2] - The net profit after deducting non-recurring gains and losses for Q1 2024 was CNY 16.72 million, a decline of 26.75% compared to the previous year[2] - Basic earnings per share for Q1 2024 were CNY 0.07, a decrease of 12.50% from CNY 0.08 in the same period last year[2] - For the full year 2023, the company reported revenue of CNY 3,778.76 million, a growth of 10.95% year-over-year[6] - The net profit attributable to shareholders for 2023 was CNY 175.35 million, reflecting a year-over-year increase of 31.51%[6] Cash Flow and Assets - Operating cash flow for Q1 2024 increased significantly by 150.24% to CNY 104.40 million[2] - Total assets at the end of Q1 2024 were CNY 7,437.45 million, a slight decrease of 0.35% from the end of the previous year[3] - Shareholders' equity increased by 1.70% to CNY 1,597.45 million at the end of Q1 2024[3] Future Plans - The company plans to enhance the quality of information disclosure to prevent similar errors in the future[6]

证券代码：002783 证券简称：凯龙股份 公告编号：2024－017 湖北凯龙化工集团股份有限公司 第八届董事会第三十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 湖北凯龙化工集团股份有限公司（以下简称"公司"）第八届董事会第三十七 次会议于2024年4月28日上午8:30在公司办公楼二楼会议室召开。本次会议由公 司董事长邵兴祥先生召集并主持，会议通知于2024年4月18日以专人送达、电子 邮件、电话等形式发出。本次会议采取现场及通讯表决方式召开，应参加本次会 议表决的董事11人，实际参加本次会议的董事为11人（其中独立董事刘捷先生以 通讯方式参与本次会议）。公司监事、部分高级管理人员列席了本次会议。本次 会议的召集、召开和表决程序符合《公司法》和《公司章程》的有关规定，合法 有效。 二、董事会会议审议情况 1．审议通过《公司2023年度总经理工作报告》 公司董事会认真听取并审议了公司总经理罗时华先生所作的《2023年度总经 理工作报告》，该报告客观、真实地反映了公司管理层2023年度落实董事会决议、 管理生产经营 ...

Financial Performance - The company's operating revenue for 2023 reached ¥3,778,757,833.20, representing a 10.95% increase compared to ¥3,405,945,794.86 in 2022[23]. - Net profit attributable to shareholders was ¥175,350,930.61, a 31.51% increase from ¥133,375,683.83 in the previous year[23]. - The net cash flow from operating activities increased by 86.10% to ¥488,934,555.96, up from ¥262,720,115.43 in 2022[23]. - Basic earnings per share rose to ¥0.45, reflecting a 28.57% increase from ¥0.35 in 2022[23]. - Total assets at the end of 2023 were ¥7,463,096,757.89, showing a slight decrease of 0.01% compared to the previous year[23]. - The net assets attributable to shareholders increased by 9.54% to ¥1,571,387,453.53 from ¥1,434,553,784.08 in 2022[23]. - The company reported a significant increase in net profit after deducting non-recurring gains and losses, which reached ¥176,329,198.24, compared to ¥58,825,462.46 in 2022, marking a 199.97% increase[23]. - The company experienced a quarterly revenue growth, with Q4 2023 revenue at ¥1,064,854,458.53, up from ¥927,044,710.86 in Q2 2023[28]. - The revenue from civil explosives amounted to CNY 1,630,126,709.10, accounting for 43.14% of total revenue, with a year-on-year growth of 36.95%[66]. - The revenue from ammonium nitrate and compound fertilizers decreased by 7.84% to CNY 1,194,396,134.83, which constituted 31.61% of total revenue[66]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of 1 RMB per 10 shares to all shareholders, with no bonus shares issued[3]. - The proposed cash dividend for 2023 is RMB 1 per 10 shares, with an estimated total cash dividend of RMB 49.98 million based on 499,795,666 shares[183]. - The company plans to distribute at least 30% of the distributable profits in cash annually from 2023 to 2025, contingent on profitability and cash flow sufficiency[180]. - In 2022, the company distributed a cash dividend of RMB 1 per 10 shares, totaling RMB 39.12 million, based on 391,238,834 shares[181]. Market Expansion and Strategic Initiatives - The company is focused on expanding its market presence and enhancing its product offerings in the civil explosives sector[16]. - The company has expanded its sales coverage to most regions in China and is one of the enterprises with the widest sales coverage in the civil explosives market[37]. - The company plans to increase its efforts in mergers and acquisitions in 2024, aiming to rank higher in key economic indicators within the industry[40]. - The company is actively pursuing strategic acquisitions to enhance its product portfolio and market share[149]. - The company is expanding its market presence, targeting new regions in Southeast Asia, with an estimated investment of 100 million RMB for market entry[157]. Research and Development - The company is developing a safety monitoring platform to enhance automation and safety in production lines, which is expected to improve operational efficiency[87]. - The number of R&D personnel increased to 257 in 2023, up by 4.05% from 247 in 2022, with R&D personnel accounting for 6.89% of the total workforce[89]. - R&D investment amounted to ¥80,709,059.72 in 2023, representing a 20.58% increase from ¥66,935,964.69 in 2022, and R&D investment as a percentage of operating revenue rose to 2.14% from 1.97%[89]. - The company is focusing on the development of nano-calcium carbonate products for photovoltaic adhesives, anticipating a significant increase in demand due to the growth of the photovoltaic industry[88]. - The company has completed research on ultrasonic welding technology for explosive products, aiming to enhance product performance and safety[87]. Safety and Compliance - The company emphasizes the importance of safety management, particularly in the explosive materials industry, to prevent potential accidents[121]. - The company invested 41 million yuan in safety-related expenditures in 2023, emphasizing its commitment to safety improvements[75]. - A total of 3,177 safety hazards were identified and rectified in 2023, achieving a 100% completion rate for rectifications[74]. - The company conducted 133 emergency response drills in 2023, enhancing employee preparedness for safety incidents[76]. - The company’s safety training programs achieved a 100% certification rate for all employees, including new hires and those in special operations[73]. Governance and Management - The board of directors convened 12 meetings during the reporting period, approving 67 agenda items, ensuring compliance with governance standards[133]. - The supervisory board held 8 meetings, reviewing 41 proposals, and ensuring the protection of shareholder rights[134]. - The management team organized over 30 meetings, addressing more than 260 topics related to operations and project development, enhancing decision-making efficiency[135]. - The company maintains complete independence from its controlling shareholders in terms of business operations, personnel, assets, and financial management, ensuring no interference in decision-making[140][142]. - The company has established an independent financial department and accounting system, ensuring independent financial decision-making and tax compliance[142]. Financial Health and Investment - The company's liquidity ratios have been low, with a high debt-to-asset ratio, indicating a relatively weak debt repayment capacity and increasing financial risk[123]. - The financial health of the company remains strong, with a current ratio of 2.5, indicating good liquidity and ability to meet short-term obligations[161]. - The company has a long-term investment strategy focused on expanding its market presence in the energy sector[99]. - The company reported a total investment of 1,900 million in the acquisition of a new explosives manufacturing facility, representing a 7.50% ownership stake[99]. - The company has achieved a 100% completion rate for the construction of its technical center expansion project, with an investment of RMB 3,216,430.00[110]. Product Development and Innovation - The company is actively researching and developing new products to meet specific customer requirements, such as automotive adhesive nano-calcium carbonate with a viscosity reduction target of 40,000-50,000 cp[88]. - New product development includes the launch of a specialized chemical product line, expected to contribute an additional 200 million RMB in revenue[157]. - The company is investing in new technologies, allocating 50 million RMB towards R&D for innovative chemical solutions[157]. - The company has completed the development of a new functional compound fertilizer that incorporates trace elements, utilizing existing production lines[88]. Environmental and Social Responsibility - The company has a commitment to environmental and social responsibilities as outlined in the annual report[5]. - The company is focused on sustainability initiatives, with a goal to reduce carbon emissions by 25% over the next five years[157]. Challenges and Risks - The report highlights potential risks in future operations, which investors are advised to consider[3]. - The company has experienced integration challenges due to regional and cultural differences following recent acquisitions[127]. - The gross margin of the company's main business has shown fluctuations, influenced by raw material prices and sales pricing capabilities, which could adversely affect profitability if negative changes occur[124].

证券代码：002783 证券简称：凯龙股份 公告编号：2024－032 湖北凯龙化工集团股份有限公司 关于举行 2023 年度业绩网上说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 湖北凯龙化工集团股份有限公司（以下简称"公司"）定于2024年5月16日（星 期四）下午15:00-17:00举行2023年度业绩说明会。本次年度业绩说明会将采用网 络远程方式举行，投资者可登陆同顺路演平台（https://board.10jqka.com.cn/ir）或 者同花顺 App 端入口（同花顺 App 首页-搜索-路演平台）参与本次说明会。 欢迎广大投资者积极参与！ 特此公告。 湖北凯龙化工集团股份有限公司董事会 2024年4月30日 出席本次说明会的人员有：公司董事长邵兴祥先生，董事会秘书孙洁先生， 财务负责人张勇先生，独立董事王晓清先生。 为充分尊重投资者、提升交流的针对性，现就公司2023年度业绩说明会提前 向投资者公开征集问题。投资者可于2024年5月15日下午17:00前访问同花顺App 端入口（同花顺App首页-更多-特色服务-路演平台）进入公 ...

湖北凯龙化工集团股份有限公司 二〇二四年四月 湖北凯龙化工集团股份有限公司 上市公告书 发行人全体董事声明 本公司全体承诺本上市公告书不存在虚假记载、误导性陈述或重大遗漏，并 对其真实性、准确性、完整性承担相应的法律责任。 向特定对象发行股票 上市公告书 保荐人（联席主承销商） 联席主承销商 王晓清 乔枫革 陈永涛 文正良 卢卫东 刘 哲 刘 捷 娄爱东 湖北凯龙化工集团股份有限公司 上市公告书 全体董事签名： 邵兴祥 罗时华 邵 峰 湖北凯龙化工集团股份有限公司 年 月 日 湖北凯龙化工集团股份有限公司 上市公告书 湖北凯龙化工集团股份有限公司 上市公告书 湖北凯龙化工集团股份有限公司 上市公告书 湖北凯龙化工集团股份有限公司 上市公告书 三、限售期安排 本次发行完成后，中荆集团认购的本次发行的股票，自新增股份上市之日起 18 个月内不得转让，自 2024 年 4 月 26 日起开始计算。除中荆集团外，其他发 行对象通过本次发行认购的股份自新增股份上市之日起 6 个月内不得转让，自 2024 年 4 月 26 日起开始计算。获配投资者在锁定期内，委托人、合伙人不得转 让其持有的产品份额或退出合伙。法律法规、 ...

之 上市保荐书 保荐人（主承销商） 中国（上海）自由贸易试验区世纪大道 1198 号 28 层 长江证券承销保荐有限公司 关于湖北凯龙化工集团股份有限公司 向特定对象发行股票 二О二四年四月 湖北凯龙化工集团股份有限公司向特定对象发行股票申请文件 上市保荐书 声 明 长江证券承销保荐有限公司（以下简称"长江保荐"或"保荐人"）及其保 荐代表人已根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共 和国证券法》（以下简称《证券法》）等法律法规和中国证监会及深圳证券交易所 的有关规定，诚实守信，勤勉尽责，严格按照依法制定的业务规则和行业自律规 范出具上市保荐书，并保证所出具文件真实、准确、完整。 除非特别注明，本上市保荐书所使用的简称和术语与《湖北凯龙化工集团股 份有限公司 2023 年度向特定对象发行股票募集说明书》一致。 1 湖北凯龙化工集团股份有限公司向特定对象发行股票申请文件 上市保荐书 一、发行人基本情况 （一）发行人概况 | 发行人名称（中文） | 湖北凯龙化工集团股份有限公司 | | --- | --- | | 发行人名称（英文） | HUBEI KAILONG CHEMICAL GRO ...

《湖北凯龙化工集团股份有限公司向特定对象发行股票上市公告书》及相关 文件已于同日在中国证券监督管理委员会指定的信息披露网站巨潮资讯网 (http://www.cninfo.com.cn)上披露，敬请广大投资者查阅。 特此公告。 湖北凯龙化工集团股份有限公司董事会 2024 年 4 月 24 日 证券代码：002783 证券简称：凯龙股份 公告编号：2024-014 湖北凯龙化工集团股份有限公司 关于向特定对象发行股票上市公告书披露的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 ...

证券代码：002783 证券简称：凯龙股份 公告编号：2024-015 湖北凯龙化工集团股份有限公司 关于公司董事、监事、高级管理人员持股情况变动的报告 湖北凯龙化工集团股份有限公司（以下简称"公司"）于 2024 年 2 月 6 日收 到中国证券监督管理委员会出具的《关于同意湖北凯龙化工集团股份有限公司向 特定对象发行股票注册的批复》（证监许可〔2024〕221 号）注册批复，同意公 司向特定对象发行股票的注册申请。截至本公告披露日，公司已成功向 21 名特 定对象发行 A 股股票 108,556,832 股（以下简称"本次发行"）。 公司董事、监事和高级管理人员均未参与本次发行，其所持本公司股份数量 未因本次发行而发生变化。 特此公告。 湖北凯龙化工集团股份有限公司董事会 2024 年 4 月 24 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 ...